Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Jounce Therapeutics Inc (NQ: JNCE )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Jounce Therapeutics Inc

< Previous 1 2 3 Next >
Why Enovix Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
JNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Jounce Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off the day with a look at all the biggest pre-market stock movers traders need to know about on Thursday! 
Via InvestorPlace
Jounce Therapeutics Shares Fall After Disappointing Mid-Stage Lung Cancer Trial Data
Via Benzinga
Tesla To $205? Here Are 10 Other Price Target Changes For Tuesday
Goldman Sachs cut Tesla, Inc. (NASDAQ: TSLA) price target from $235 to $205. Goldman Sachs analyst Mark Delaney maintained a Buy rating on the stock. Tesla shares fell 2.6% to $119.93 in pre-market... 
Via Benzinga
Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Gilead Sciences Acquires Jounce Therapeutics Cancer Immunotherapy Program
Via Benzinga
Why Is Jounce Therapeutics (JNCE) Stock Up 70% Today?
Gilead will try to win approval for what is now GS-1811, while Jounce develops other immunotherapy drugs. JNCE stock is soaring. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Minerva Surgical Shares Are Trading Higher By 166%; Here Are 26 Stocks Moving Premarket
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 166% to $0.4327 in pre-market trading after the company reported a $30 million private placement of common stock led by Accelmed Partners. 
Via Benzinga
Cal-Maine Foods, Kala Pharmaceuticals And 3 Stocks To Watch Heading Into Wednesday
With US stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Gilead to Acquire All Remaining Rights to Potential First-in-Class Immunotherapy GS-1811 From Jounce Therapeutics
From Gilead Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Why Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving Premarket
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares rose 74.7% to $0.4104 in pre-market trading after declining 4% on Wednesday. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 49 companies hit new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 34 companies set new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2022
Upgrades 
Via Benzinga
NVIDIA To $225? Plus Raymond James Cuts PT On This Stock By 81%
Oppenheimer cut the price target on NVIDIA Corporation (NASDAQ: NVDA) from $250 to $225. Oppenheimer analyst Rick Schafer maintained an Outperform rating on the stock. NVIDIA shares rose 0.9% to... 
Via Benzinga
Susquehanna Slashes Price Target On This Stock By 60%; Also Check Out Some Other Major PT Changes
Susquehanna cut the price target on Paysafe Limited (NYSE: PSFE) from $5 to $2. Susquehanna analyst James Friedman also downgraded the stock from Positive to Neutral. Paysafe shares fell 1.7% to $1.79... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 63 stocks hit new 52-week lows. 
Via Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
  
Via Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Why Nikola Dropped Over 9%; Here Are 66 Biggest Movers From Yesterday
Gainers Mobile Global Esports Inc. (NASDAQ: MGAM) shares surged 103.9% to settle at $5.30 on Tuesday. Shares are in low-float territory; the issue has about 15 million shares in its float. 
Via Benzinga
Earnings Outlook For Jounce Therapeutics
Jounce Therapeutics (NASDAQ:JNCE) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that Jounce... 
Via Benzinga
Why IN8bio Is Trading Higher By 46%, Here Are 54 Stocks Moving In Tuesday's Mid-Day Session
Gainers NewAge, Inc. (NASDAQ: NBEV) rose 54.4% to $0.3220. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
During the Thursday's session, 100 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 73 stocks hit new 52-week lows. 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.